NOT KNOWN FACTUAL STATEMENTS ABOUT MBL77

While lower-depend MBL seldom progresses to CLL, superior-count MBL progresses to CLL demanding therapy at a price of 1% to two% per year. High-depend MBL is distinguished from Rai 0 CLL dependant on whether or not the B-cell depend is higher than or below 5 × 109/L. Although people today with both equally high-depend MBL and CLL Rai phase 0 are a